Need more? Try out  Advanced Search (20+ criteria)»

Last Update

is this you? Claim your profile.

Wrong William Kerns?

William D. Kerns

Chief Executive Officer

Accellient Partners LLC

HQ Phone:  (617) 538-5688

Direct Phone: (978) ***-****direct phone

Email: b***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Accellient Partners LLC

1000 Winter Street, Suite 2000

Waltham, Massachusetts,02451

United States

Company Description

Accellient was founded by a team of seasoned life science experts with years of pharma/biotech, CRO and consulting experience. The Accellient Partners' team brings a unique combination of knowledge and innovative thinking to product development across all ther... more.

Find other employees at this company (10)

Background Information

Employment History

Vice President Drug Development

Can-Fite BioPharma Ltd


Position, Pharmaceutical Research and Development

SmithKline Beecham Corporation


Position, Pharmaceutical Research and Development

Eisai Research Institute


Affiliations

Sphaera Pharma

Scientific Advisory Board Member


Synchroneuron Inc

Board Member


NTSRI

Treasurer


Taiwan Liposome Company

Scientific Advisory Board Member


Critical Path Institute

Advisor


Calvert Holdings , Inc.

Board Member


Ricerca Biosciences LLC

Scientific Advisory Board


Education

American College of Veterinary Pathologists


DVM


DVM

The Ohio State University


MS


MS

Ohio State University


undergraduate degree

Wilmington College


Web References(69 Total References)


Scientific Advisory Board

www.sphaerapharma.com [cached]

William D. Kerns, DVM, MS, DACVP
Dr. William Kerns, has over 25 years of experience in Drug Discovery and Development. In addition to his role at Sphaera Pharma, he is the CEO of Accellient Partners LLC. Read more


Accellient Partners | Management Team

www.accellient.com [cached]

Bill Kerns, DVM, MS, DACVP
Partner Chief Executive Officer Regulatory & Drug Development


Scientific Advisory Board

www.sphaerapharma.com [cached]

William D. Kerns, DVM, MS, DACVP


Synchroneuron | Board of Directors

www.synchroneuron.com [cached]

William D Kerns DVM, MS
Interim CEO Dr. Kerns is an entrepreneur and co-founder of Synchroneuron Inc. He completed his medical training in Veterinary Medicine and graduate work in Pharmacology and Pathology at The Ohio State University. In his graduate program, he studied molecular mechanisms of cardiac hypertrophy. In 1980, he successfully completed examination by the American College of Veterinary Pathologists. Dr. Kerns has 30 years of experience in pharmaceutical research and development, having held senior executive positions in preclinical development at SmithKlineFrench, SmithKlineBeecham (both now part of GlaxoSmithKline), and Eisai during his pharmaceutical career. He is recognized as an expert in drug development and safety assessment with a focus on mechanisms of drug-induced cardiovascular toxicity. He has authored or co-authored over 100 articles and has co-edited a book on cardiovascular toxicology. He has been actively involved in the SOT, STP and ACVP and he has co-chaired an FDA expert committee on biomarkers of drug-induced vascular injury. . Dr. Kerns has participated in the successful management and activation of over 200 INDs and 15 NDAs during his career. Currently he oversees the submission of 3-4 INDs each year across multiple divisions at FDA. Dr. Kerns is also a co-founder and the CEO of Accellient Partners, LLC, a drug development consultancy.


Synchroneuron | Management Team

www.synchroneuron.com [cached]

William D Kerns DVM, MS, DACVP
Interim CEO Dr. Kerns is an entrepreneur and co-founder of Synchroneuron Inc. He completed his medical training in Veterinary Medicine and graduate work in Pharmacology and Pathology at The Ohio State University. In his graduate program, he studied molecular mechanisms of cardiac hypertrophy. In 1980, he successfully completed examination by the American College of Veterinary Pathologists. Dr. Kerns has 30 years of experience in pharmaceutical research and development, having held senior executive positions in preclinical development at SmithKlineFrench, SmithKlineBeecham, and Eisai during his pharmaceutical career. He is recognized as an expert in drug development and safety assessment and an expert on mechanisms of drug-induced cardiovascular toxicity. He has authored or co-authored over 100 articles and has co-edited a book on cardiovascular toxicology. He has been actively involved in the SOT, STP and ACVP and he has co-chaired an FDA expert committee on biomarkers of drug-induced vascular injury. . Dr. Kerns has participated in the successful management and activation of over 200 INDs and 15 NDAs during his career. Currently he oversees the submission of 3-4 INDs each year across multiple divisions at FDA. . Dr. Kerns is also a co-founder and the CEO of Accellient Partners, LLC, a drug development consultancy in Waltham, MA.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory